Skip to main content
Home

Generic substitute for gadolinium-based contrast agent Gadavist hits the market

gadolinium, GBCAs

The contrast agent, simply called Gadobutrol Injection, has been approved by the U.S. Food and Drug Administration and is now available in the United States.

  • Read more about Generic substitute for gadolinium-based contrast agent Gadavist hits the market

Relaxed fasting instructions prior to TAVR, other heart procedures do not affect outcomes

fasting before tavr or ablation

Fasting before major operations has been common in healthcare for nearly 80 years, but that has started to change since the turn of the century. 

  • Read more about Relaxed fasting instructions prior to TAVR, other heart procedures do not affect outcomes

Walgreens-backed VillageMD launches ‘major imaging hub’ open 7 days a week

Walgreens

The “first imaging department of its kind” will deliver CT, ultrasound, X-ray, fluoroscopy and ambient MRI, all in one location. 

  • Read more about Walgreens-backed VillageMD launches ‘major imaging hub’ open 7 days a week

Surgery, interventional therapies still the best choice for many HCM patients

Video of Hari Naidu, MD, director of the Hypertrophic Cardiomyopathy Center of Excellence at Westchester Medical Center, explaining the role of alcohol septal ablation and surgical myectomy in the era of mavacamten. #HCM #ASE

"You have to look at each patient and understand their goals," one HCM expert said in a new interview. 

  • Read more about Surgery, interventional therapies still the best choice for many HCM patients

FDA approves Boston Scientific’s new cryoablation system for AFib

Boston Scientific’s POLARx Cryoablation System to treat atrial fibrillation gained FDA approval in August 2023. It is compatible with two balloon sizes, 31 and 28 mm to fit different sized anatomies.

Boston Scientific’s POLARx Cryoablation System to treat atrial fibrillation.

The system includes an expandable cryoablation balloon catheter compatible with multiple balloon sizes. 

  • Read more about FDA approves Boston Scientific’s new cryoablation system for AFib

MRI finding linked to heightened cancer risk among women with very dense breasts

 background parenchyma enhancement breast MRI

Representative transverse dynamic contrast-enhanced MRI scans in patients in the high (left) and low (right) tertiles of volume of enhancing parenchyma. 

A new AI model helped researchers identify a relationship between background parenchyma enhancement on breast MRI exams and breast cancer risk.

  • Read more about MRI finding linked to heightened cancer risk among women with very dense breasts

Rethinking ICM storage could help imaging departments reduce waste by 59%

contrast shortage

“While drug pricing is not opaque and absolute costs of medications can vary widely, any waste comes at a cost," researchers wrote in a new analysis. 

  • Read more about Rethinking ICM storage could help imaging departments reduce waste by 59%

Rising patient volumes and staffing challenges: 7 takeaways from a new salary survey of radiologists, techs and administrators

radiology survey

The 2023 Radiology Business Salary and Job Satisfaction Report includes survey responses from all members of the imaging team. 

  • Read more about Rising patient volumes and staffing challenges: 7 takeaways from a new salary survey of radiologists, techs and administrators

How medical imaging helps cardiologists treat hypertrophic cardiomyopathy

HCM expert Sherif F. Nagueh, MD, FACC, FASE, professor of cardiology, Methodist DeBakey Heart and Vascular Center, explains the key points of HCM imaging. #ASE #HCM

Hypertrophic cardiomyopathy expert Sherif F. Nagueh, MD, examined imaging's role in treating this serious condition. 

  • Read more about How medical imaging helps cardiologists treat hypertrophic cardiomyopathy

A surgeon's perspective on treating hypertrophic cardiomyopathy

Photo of a surgical cardiac septal myectomy to treat hypertrophic cardiomyopathy (HCM). Nicholas Smedira MD discusses septal myectomy in HCM patients and the need for more detailed protocols for HCM care. #HCM #ASE #ASE2023 #myectomy

Nicholas Smedira, MD, a cardiovascular surgeon with Cleveland Clinic, discusses septal myectomy and the need to improve overall HCM care with new standards and evidence-based guidelines.

  • Read more about A surgeon's perspective on treating hypertrophic cardiomyopathy

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …808
    • Page 809
    • Page 810
    • Page 811
    • Current page 812
    • Page 813
    • Page 814
    • Page 815
    • Page 816 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme